GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (XSWX:SKAN) » Definitions » FCF Margin %

SKAN Group AG (XSWX:SKAN) FCF Margin % : -6.35% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SKAN Group AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. SKAN Group AG's Free Cash Flow for the six months ended in Dec. 2023 was CHF-11.5 Mil. SKAN Group AG's Revenue for the six months ended in Dec. 2023 was CHF180.3 Mil. Therefore, SKAN Group AG's FCF Margin % for the quarter that ended in Dec. 2023 was -6.35%.

As of today, SKAN Group AG's current FCF Yield % is -1.42%.

The historical rank and industry rank for SKAN Group AG's FCF Margin % or its related term are showing as below:

XSWX:SKAN' s FCF Margin % Range Over the Past 10 Years
Min: -13.78   Med: -2.05   Max: 11.78
Current: -8.31


During the past 4 years, the highest FCF Margin % of SKAN Group AG was 11.78%. The lowest was -13.78%. And the median was -2.05%.

XSWX:SKAN's FCF Margin % is ranked worse than
51.33% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: -7.13 vs XSWX:SKAN: -8.31


SKAN Group AG FCF Margin % Historical Data

The historical data trend for SKAN Group AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG FCF Margin % Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Margin %
4.21 -13.78 11.78 -8.31

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Margin % Get a 7-Day Free Trial -11.51 9.26 13.73 -10.84 -6.35

Competitive Comparison of SKAN Group AG's FCF Margin %

For the Medical Instruments & Supplies subindustry, SKAN Group AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SKAN Group AG's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where SKAN Group AG's FCF Margin % falls into.



SKAN Group AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

SKAN Group AG's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-26.598/320.02
=-8.31 %

SKAN Group AG's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-11.455/180.282
=-6.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SKAN Group AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of SKAN Group AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SKAN Group AG (XSWX:SKAN) Business Description

Traded in Other Exchanges
Address
Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system.

SKAN Group AG (XSWX:SKAN) Headlines

No Headlines